Zum Inhalt springen

New CD Laboratory as foundation for future therapies

07.03.2024: The Christian Doppler Laboratory for Knowledge-based Production of Gene Therapy Vectors opens at BOKU Wien.

So-called "rAAVs" (recombinant adeno-associated viruses) have great potential for treating or curing diseases caused by missing or defective genes: Head of Laboratory Astrid Dürauer (pictured) and her team, supported by commercial partner Boehringer Ingelheim International GmbH, work on laying important foundations in this field to contribute to a future in which these promising medications can be made available to patients efficiently and in sufficient quantities!

Further information on the CD Laboratory

Press release (BOKU Wien)